ZIP4 silencing improves bone loss in pancreatic cancer

Metabolic bone disorders are associated with several types of human cancers. Pancreatic cancer patients usually suffer from severe nutrition deficiency, muscle wasting, and loss of bone mass. We have previously found that silencing of a zinc transporter ZIP4 prolongs the survival and reduces the sev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget 2015-09, Vol.6 (28), p.26041-26051
Hauptverfasser: Zhang, Qiang, Sun, Xiaotian, Yang, Jingxuan, Ding, Hao, LeBrun, Drake, Ding, Kai, Houchen, Courtney W, Postier, Russell G, Ambrose, Catherine G, Li, Zhaoshen, Bi, Xiaohong, Li, Min
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!